Vascularisation of pluripotent stem cell–derived myocardium: biomechanical insights for physiological relevance in cardiac tissue engineering
Authors:
Open Access
- 14 April 2021
- journal article
- review article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 473 (7) , 1117-1136
Abstract
The myocardium is a diverse environment, requiring coordination between a variety of specialised cell types. Biochemical crosstalk between cardiomyocytes (CM) and microvascular endothelial cells (MVEC) is essential to maintain contractility and healthy tissue homeostasis. Yet, as myocytes beat, heterocellular communication occurs also through constantly fluctuating biomechanical stimuli, namely (1) compressive and tensile forces generated directly by the beating myocardium, and (2) pulsatile shear stress caused by intra-microvascular flow. Despite endothelial cells (EC) being highly mechanosensitive, the role of biomechanical stimuli from beating CM as a regulatory mode of myocardial-microvascular crosstalk is relatively unexplored. Given that cardiac biomechanics are dramatically altered during disease, and disruption of myocardial-microvascular communication is a known driver of pathological remodelling, understanding the biomechanical context necessary for healthy myocardial-microvascular interaction is of high importance. The current gap in understanding can largely be attributed to technical limitations associated with reproducing dynamic physiological biomechanics in multicellular in vitro platforms, coupled with limited in vitro viability of primary cardiac tissue. However, differentiation of CM from human pluripotent stem cells (hPSC) has provided an unlimited source of human myocytes suitable for designing in vitro models. This technology is now converging with the diverse field of tissue engineering, which utilises in vitro techniques designed to enhance physiological relevance, such as biomimetic extracellular matrix (ECM) as 3D scaffolds, microfluidic perfusion of vascularised networks, and complex multicellular architectures generated via 3D bioprinting. These strategies are now allowing researchers to design in vitro platforms which emulate the cell composition, architectures, and biomechanics specific to the myocardial-microvascular microenvironment. Inclusion of physiological multicellularity and biomechanics may also induce a more mature phenotype in stem cell–derived CM, further enhancing their value. This review aims to highlight the importance of biomechanical stimuli as determinants of CM-EC crosstalk in cardiac health and disease, and to explore emerging tissue engineering and hPSC technologies which can recapitulate physiological dynamics to enhance the value of in vitro cardiac experimentation.Keywords
Funding Information
- National Heart and Lung Foundation
- British Heart Foundation
This publication has 219 references indexed in Scilit:
- The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cellsBiomaterials, 2013
- In Vitro Engineering of Vascularized Tissue SurrogatesScientific Reports, 2013
- Multiple influences of blood flow on cardiomyocyte hypertrophy in the embryonic zebrafish heartDevelopmental Biology, 2012
- The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formationMolecular Biology of the Cell, 2011
- Responses of endothelial cells to extremely slow flowsBiomicrofluidics, 2011
- Cell Communications in the HeartCirculation, 2010
- Reversing Blood Flows Act through klf2a to Ensure Normal Valvulogenesis in the Developing HeartPLOS Biology, 2009
- TRPV4 Channels Mediate Cyclic Strain–Induced Endothelial Cell Reorientation Through Integrin-to-Integrin SignalingCirculation Research, 2009
- Endothelium as master regulator of organ development and growthVascular Pharmacology, 2009
- Cardiac growth and angiogenesis coordinated by intertissue interactionsJournal of Clinical Investigation, 2007